Work

Moringa oleifera Seed Antimicrobial Peptides: Mechanisms, Matrix Validation, and Barriers to Food Applications

Year: 2026
Type: article
Abstract: “Meal-to-protein-to-peptide” is the organizing logic of this review. Moringa (Moringa oleifera Lam.) seed cake, the protein-rich (35–63% protein) by-product of oil extraction, is currently used mainly as a water-treatment coagulant, yet its proteins and peptides have rarely been assessed as food preservatives. We separate three molecular classes: seed defense proteins and peptides (2S albumins and napins, chitin-binding proteins, morintides, hevein-like peptides, lectins, and cationic coagulant peptides), peptides released by enzymatic hydrolysis, and seed-derived isothiocyanates as non-protein comparators. Evidence is graded on three tiers: direct mechanistic experiments, measured antimicrobial activity, and food-matrix validation. Membrane disruption is experimentally supported; omics data show multi-target perturbation; intracellular targets for MOp2 remain docking predictions. Matrix evidence is narrow: only MOp3 and one isothiocyanate have been validated in milk, and no purified seed peptide has been tested in an edible film. Reported minimum inhibitory concentrations span 16–32 µg/mL to about 2 mg/mL, corresponding to food-addition levels of roughly 16–2000 mg/kg. Dose feasibility and safety/regulatory clearance are therefore treated as parallel barriers to translation. We provide a minimum reporting checklist, a translational roadmap for meat, seafood, and films, and a comparison of Moringa peptides with the broader antimicrobial peptide field.
Source: Molecules
Language: English
Subfield: Microbiology
Open Access status: gold
Estimated APC paid: $3,258
OpenAlex ID: W7236788654
FWCI:
Cites: 123
Cited by:
Related to: 10